Graham Parry
Stock Analyst at Citi
(2.28)
# 3,112
Out of 5,073 analysts
236
Total ratings
60.6%
Success rate
0.7%
Average return
Main Sectors:
Stocks Rated by Graham Parry
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LON: AZN AstraZeneca PLC | Reiterated: Buy | n/a | $12,614.00 | - | 17 | Oct 12, 2026 | |
| SWX: NOVN Novartis AG | Reiterated: Buy | n/a | $126.88 | - | 55 | Oct 6, 2026 | |
| LON: GSK GSK plc | Reiterated: Hold | 2,100p | 1,868p | +12.42% | 54 | Sep 15, 2026 | |
| SWX: ROP Roche Holding AG | Reiterated: Buy | n/a | $392.00 | - | 5 | Mar 10, 2026 | |
| EPA: SAN Sanofi | Reiterated: Hold | €85.00 → €80.00 | €73.57 | +8.74% | 40 | Feb 20, 2026 | |
| SNY Sanofi | Reiterated: Buy | n/a | $40.97 | n/a | 17 | Jan 31, 2025 | |
| GSK GSK plc | Reiterated: Sell | $19 | $50.02 | n/a | 23 | Dec 6, 2024 | |
| NVS Novartis AG | Rated: Hold | $118 → $130 | $153.93 | n/a | 17 | Sep 11, 2024 | |
| BME: GRF Grifols, S.A. | Initiated Coverage: Buy | €20.00 | €10.09 | n/a | 1 | Sep 12, 2023 | |
| LON: HLN Haleon plc | Reiterated: Buy | 358p → 624p | 373p | n/a | 2 | Mar 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $88 | $153.57 | n/a | 1 | Mar 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $50 | $29.85 | n/a | 1 | Feb 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | n/a | $39.57 | n/a | 1 | Sep 10, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $34 | $59.11 | n/a | 1 | Sep 10, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | n/a | $3.81 | n/a | 1 | Oct 26, 2017 |
AstraZeneca PLC
Oct 12, 2026
Reiterated: Buy
Price Target: n/a
Current: $12,614.00
Upside: -
Novartis AG
Oct 6, 2026
Reiterated: Buy
Price Target: n/a
Current: $126.88
Upside: -
GSK plc
Sep 15, 2026
Reiterated: Hold
Price Target: 2,100p
Current: 1,868p
Upside: +12.42%
Roche Holding AG
Mar 10, 2026
Reiterated: Buy
Price Target: n/a
Current: $392.00
Upside: -
Sanofi
Feb 20, 2026
Reiterated: Hold
Price Target: €85.00 → €80.00
Current: €73.57
Upside: +8.74%
Sanofi
Jan 31, 2025
Reiterated: Buy
Price Target: n/a
Current: $40.97
Upside: n/a
GSK plc
Dec 6, 2024
Reiterated: Sell
Price Target: $19
Current: $50.02
Upside: n/a
Novartis AG
Sep 11, 2024
Rated: Hold
Price Target: $118 → $130
Current: $153.93
Upside: n/a
Grifols, S.A.
Sep 12, 2023
Initiated Coverage: Buy
Price Target: €20.00
Current: €10.09
Upside: n/a
Haleon plc
Mar 7, 2023
Reiterated: Buy
Price Target: 358p → 624p
Current: 373p
Upside: n/a
Mar 3, 2023
Reiterated: Hold
Price Target: $88
Current: $153.57
Upside: n/a
Feb 28, 2023
Reiterated: Hold
Price Target: $50
Current: $29.85
Upside: n/a
Sep 10, 2018
Downgraded: Sell
Price Target: n/a
Current: $39.57
Upside: n/a
Sep 10, 2018
Downgraded: Hold
Price Target: $34
Current: $59.11
Upside: n/a
Oct 26, 2017
Downgraded: Sell
Price Target: n/a
Current: $3.81
Upside: n/a